Protein A Resins Market will secure 8.4% growth to hit $900 million by 2024
SELLBYVILLE, Del., Jan. 16, 2018 /PRNewswire-iReach/ -- Global Protein A Resins Market is expected to cross USD 900 million by 2024; as per a new research report by Global Market Insights, Inc.
Protein A resins are crucial and are broadly used as purification and separation materials owing to high resolution, across the biopharmaceutical industry. They exploit the chemical and physical variances among biomolecules for separation of antibodies by immunoprecipitation and antibody purification. Growing diagnostic and therapeutic applications of monoclonal antibodies will be the major driver for protein A resins market size.
High selectivity and improved antibody yield coupled with ease of operation in large and small-scale antibody purification and immunoprecipitation will further drive the protein A resins market growth. Chromatography with these has several advantages as a separation method, over conventional techniques like solvent extraction, crystallization, and distillation. For instance, it can separate all the components of a multicomponent biochemical mixture without demanding a detailed foreknowledge of the number, identity, or relative quantities of the materials present in the mixture.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1146
U.S. market growth will continue to dominate other regions due to presence of well-established infrastructure for clinical trials. Recombinant protein A resins market will grow at significant CAGR of around 8% during the forecast period owing to the wealth of techniques and products used for their expression and purification. Contract research organizations (CROs) provide modified solutions for monoclonal antibody and recombinant protein production from mammalian cell culture. The segment accounted for second highest revenue share of around 15%. CROs also offer large-scale protein production and virus production, making it suitable for pharmaceutical and biotechnology companies as well as academic institutions to outsource processes.
Browse key industry insights spread across 127 pages with 123 market data tables & around 8 figures & charts from the report, "Protein A Resins Market" in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/protein-a-resins-market
In 2015, Spain protein A resins market size was over USD 25 million, increasing investments by public and private companies in the development of biosimilars and increasing demand for biosimilar products are the significant factors driving the market for monoclonal antibodies and eventually Spain market growth.
Asia Pacific protein A resins market will grow at highest CAGR of over 8.5%, favorable government policies, dynamic infrastructure development will attract international companies to set-up manufacturing plants in the region and availability of skilled professionals at affordable costs. The region has emerged as a preferred destination for contract research organizations and various biopharmaceutical companies to establish business.
Japan protein A resins market accounted for over 40% share, as its healthcare infrastructure is experiencing noteworthy transformation. The government is strategically planning a regulatory system in which public and private companies will contribute to develop novel biosimilar products.
India antibody purification market has witnessed notable growth in recent years, which could continue in the vicinity of 10%, with factors such as increasing research into the development monoclonal antibodies, driving protein A resins market growth.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1146
Major industry companies include GE Healthcare, Repligen, GenScript, Tosoh Bioscience, Merck Millipore (EMD Millipore), Thermo Fisher Scientific, Novasep, Expedeon, Bio-Rad Laboratories, Danaher Corporation, Sigma-Aldrich, Purolite Life Sciences, Takara Bio, and Agarose Bead Technologies.
Browse Related Reports:
Point of Care (PoC) Molecular Diagnostics Market Size 2017 - 2024
Point of Care (PoC) Molecular Diagnostics Market share was over USD 1 billion in 2016, with growth forecast over 9% CAGR from 2017 to 2024. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.
https://www.gminsights.com/industry-analysis/point-of-care-poc-molecular-diagnostics-market
Esoteric Testing Market Size 2017 - 2024
Esoteric Testing Market share was over USD 18 billion in 2016, with growth forecast over 9% CAGR from 2017 to 2024. Increasing number of commercial labs coupled with surge in outsourcing activities will fuel industry growth.
https://www.gminsights.com/industry-analysis/esoteric-testing-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://www.gminsights.com/blogs
Connect with us: Facebook | Google+ | LinkedIn | Twitter
Media Contact: Arun Hegde, Global Market Insights, Inc., +13028467766, sales@gminsights.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Market Insights, Inc.
